Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapindus mukorossi extract as endodontic irrigant
NCT05038059Completed
- Sponsor
- Dow University of Health Sciences
- Start
- Apr 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of sapindus mukorossi extract in irreversible pulpitis, apical periodontitis (AP) and Endodontic infection (3 arms), sponsored by Dow University of Health Sciences. Primary endpoints: Apical microleakage at 1 month, Dentinal tubule penetration of sealer at 2 months and 1 more. Started Apr 2020; status: completed.
02
Drugs
sapindus mukorossi extract
03
Conditions
irreversible pulpitisapical periodontitis (AP)Endodontic infection
Beyond the preview
Go deeper on NCT05038059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05038059.